APA

Brisbois T. D., de Kock I. H., Watanabe S. M., Mirhosseini M., Lamoureux D. C., Chasen M., MacDonald N., Baracos V. E. & Wismer W. V. (20111128). Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Brisbois T D, de Kock I H, Watanabe S M, Mirhosseini M, Lamoureux D C, Chasen M, MacDonald N, Baracos V E and Wismer W V. 20111128. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Brisbois T. D., de Kock I. H., Watanabe S. M., Mirhosseini M., Lamoureux D. C., Chasen M., MacDonald N., Baracos V. E. and Wismer W. V. (20111128). Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Brisbois T D, de Kock I H, Watanabe S M, Mirhosseini M, Lamoureux D C, Chasen M, MacDonald N, Baracos V E and Wismer W V. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. : Annals of oncology : official journal of the European Society for Medical Oncology. 20111128.